MURPHY ANDREW J bought REGN
March 13, 2024 · Form 4 insider transaction
MURPHY ANDREW J bought 20,000 shares of Regeneron Pharmaceuticals, Inc. at $399.66 per share, a transaction worth $7.99M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$399.66
Total value
$7.99M
InsiderMURPHY ANDREW J
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 13, 2024
Filing dateMarch 15, 2024
Shares owned after68,306
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.